Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 15, 2006Clinical Cancer Research

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

View Full Paper
Ask AI
Bookmark
Share

Authors

MOMagali OlivierALAnita Langer√∏dPCPatrizia Carrieri

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Olivier et al. (2006) studied this question.

synapsesocial.com/papers/6a6fb38d439bab0cabc2e23chttps://doi.org/10.1158/1078-0432.ccr-05-1029
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1<i>p53</i> Status and the Efficacy of Cancer Therapy in Vivo1994 · 1,482 citations
  2. 2<i>TP53</i> mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains1995 · 182 citations